Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIRLET7BHG - Hyperplastic enlarged lobular units: epithelial cells
GEO DataSets Gene Profile neighbors Chromosome neighbors
MIRLET7BHG - Duchenne muscular dystrophy (HG-U95D)
MIRLET7BHG - Long-term adult survivors of glioblastoma: primary tumors
MIRLET7BHG - Androgen receptor modulator effect: time course (HG-U133B)
MIRLET7BHG - Prostate adenocarcinoma response to radiation (HG-U95C)
MIRLET7BHG - Obesity: adipocyte expression profile (HG-U95C)
GEO DataSets Gene Chromosome neighbors
MIRLET7BHG - Skeletal repair in non-union fractures (HG-U95C)
MIRLET7BHG - Obesity: adipocyte expression profile (HG-U95D)
MIRLET7BHG - Prostate adenocarcinoma response to radiation (HG-U95D)
MIRLET7BHG - Beta-catenin depletion effect on pancreatic cancer cell line
MIRLET7BHG - Endogenous miRNA transfection effect on cultured fibroblasts
MIRLET7BHG - Embryonic stem cell-derived cardiomyocytes
MIRLET7BHG - Metastatic prostate cancer (HG-U95C)
MIRLET7BHG - Bleomycin effect on mutagen-sensitive lymphoblastoid cell lines
MIRLET7BHG - Primary central nervous system lymphoma patients: brain tumor
MIRLET7BHG - Allergic contact dermatitis: time course
MIRLET7BHG - Saliva of pre-treatment pancreatic cancer patients
MIRLET7BHG - Duchenne muscular dystrophy (II) (HG-U95D)
MIRLET7BHG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIRLET7BHG - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on